◼ Archived
Business
Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 trends tracked about this subject — the full history, oldest to newest below.
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Eli Lilly has expanded its neuropsychiatric portfolio through a multi-billion dollar acquisition of Atai, a psychedelic research company.
Eli Lilly is entering the psychedelic drug market with a deal to acquire AtaiBeckley for up to $3.8 billion to treat resistant depression.